cellular mechanism of HO. [6] [7] [8] Recently, EndMT has been proven to generate endothelial-derived mesenchymal stem-like cells that participate in heterotopic bone formation. 9 EndMT occurs in response to inflammatory cytokines, such as bone morphogenetic protein (BMP)-4 and transforming growth factor (TGF)-β2 and results in the loss of adhesion between cells, changes in cell polarity and shape and generation of highly invasive and motile mesenchymal stem-like cells.
During EndMT, endothelial-specific markers, such as tyrosine kinase with immunoglobulin-like and EGF-like 1 (Tie-1), vascular endothelial cadherin (VE-cadherin) and CD31 are reduced, but mesenchymalspecific markers, such as fibroblast-specific protein 1 (FSP-1), neural cadherin (N-cadherin) and α smooth muscle actin (α-SMA), increase. 10 Previous studies indicated that endothelial cells from FOP lesions undergo inflammation-induced EndMT, acquire a mesenchymal stem-like phenotype and subsequently differentiate into osteoblasts suggesting the critical role of EndMT in HO formation. Similarly, in a model of BMP-4 and TGF-β2-induced HO, the conversion of endothelial cells to MSC-like cells via EndMT have been observed. 9, 11 Although the effect of EndMT on HO formation has been identified, unraveling the underlying regulation mechanism of EndMT in HO remains challenging.
Current studies have speculated that neuroendocrine cytokines may, in part, regulate the EndMT process. 12, 13 NT-3, a polypeptide growth factor involved in the proliferation, differentiation and apoptosis of neuronal and non-neuronal cells is believed to have neuroendocrine characteristics. 14 However, comprehensive evidence elucidating the role and mechanism of NT-3 in EndMT is lacking. Although previous studies have demonstrated that NT-3 is critical for nervous system development and maintenance, increasing evidence now suggests that NT-3 also plays a major role in the skeletal system. 15 For example, in a recent study, with its high affinity receptor (TrkC), NT-3 was identified as an important osteogenic and angiogenic factor for promoting bony healing of the injured growth plate in rats. 16, 17 Similarly, in a rat femoral distraction healing model, NT-3 localization was observed in chondrocytes and osteoblasts during the endochondral ossification process. 18 Besides, in mice rib fracture models, localization of NT-3 was observed in osteoblast-like cells and hypertrophic chondrocytes at the fracture callus. 19 In addition, NT-3 was shown to improve fracture healing in rats by regulating the tibia BMD, biomechanical indexes and bone formation. 20 Moreover, as an autocrine and paracrine factor, NT-3 was detected in osteoblast-like cells and hypertrophic chondrocytes in fracture callus in a mouse fracture healing model. 18 Although these previous studies have described the effect of NT-3 on bone healing or remodeling, the potential function and mechanism of NT-3 in the regulation of HO remain unknown. Based on previous work, we hypothesize that NT-3 may act as a neuroendocrine cytokine involved in promoting HO formation through regulation of EndMT. We used an in vivo model of HO and an in vitro model of EndMT induction to elucidate the effect and underlying molecular mechanism of NT-3 on EndMT in HO formation.
We demonstrated that the formation of heterotopic cartilage and bone is caused by EndMT and suggested a potential mechanism that NT-3 can promote the formation of HO through induction of
EndMT both in vivo and in vitro.
| MATERIAL S AND ME THODS

| Animal treatment
All animal experimental protocols were approved by the Ethics
Committee for Animal Research of Southern Medical University.
Ninety-six Sprague Dawley (SD) rats (6-week-old and regardless of gender) were purchased from the Laboratory Animal Center of Southern Medical University and subjected to an Achilles tenotomy using a posterior midpoint approach under aseptic conditions to induce HO. 21 For gene expression and histological analysis of NT-3, rats were killed at 4, 8 and 12 weeks after surgery (n = 6/ time point); a control group was also killed (n = 6). For the EndMT study, 24 injured rats were randomly divided into four groups (n = 6/group): three groups received a sub-cutaneous injection of recombinant NT-3, BMP-4 or TGF-β2 (1.2 mg/mL, receiving 12 mg injection per week) (R&D Systems, Minneapolis, MN, USA)
once a week surrounding the Achilles tendon. For the study of HO formation associated with EndMT, the injured rats were randomly divided into another four groups: the HO control, NT-3,
NT-3+dorsomorphin and dorsomorphin groups (n = 6/group). For the study of NT-3 on EndMT and HO formation, the remaining injured rats were randomly divided into another four groups: the HO control, NT-3, NT-3+GNF5837 and GNF5837 groups (n = 6/ group). Rats received an injection of NT-3 and GNF5837 (1 mg/kg) (Tocris Bioscience, Bristol, UK) weekly around the injured sites and dorsomorphin was intraperitoneally administered daily (1 mg/kg) (R&D Systems). All rats in the HO control group were administered a saline vehicle weekly. Twelve weeks after the Achilles tenotomy, all rats were killed and their limbs were collected for further study.
| Micro-CT analysis
Micro-CT scans (µCT 80, Scanco Medical, Bruttisellen, Zurich, Switzerland) were performed on limbs harvested from the experimental and control groups. Specimens were scanned with a mean 20-μm slice thickness under the conditions of 60 kV at 150 μA. HO formation was evaluated using reconstructed 3D images and ectopic bone volume was calculated.
| Histological analysis
The Achilles tendons of rats collected from the experimental and control groups were fixed, decalcified, dehydrated and processed for paraffin embedding in 4-μm-thick sections. 
| qRT-PCR analysis
Total RNA was extracted from Achilles tendon tissues or rat aortic Table S1 . Data were calculated using the 2 −△△CT method and relative gene expression in the treatment groups is presented as fold change in relation to the control group.
| Cell isolation and identification
RAOECs were isolated from SD rats as described previously. 22 The intact aorta was excised, a 6-0 suture was fixed on one end of the aorta and the inner surface of the aorta was flipped to the outside by drawing the suture through the lumen of the blood vessel with a blunt no. 5 suture needle. The turnover aorta was then cultured in endothelial cell medium (ECM) (ScienCell, Carlsbad, USA) at 37°C under 5% CO 2 . The medium was refreshed every two days. After one week, the number of adherent cells was observed under a microscope. The adherent cells were identified as endothelial cells by IF staining with CD31 and Tie-1 ( Figure S1A ). Third passage endothelial cells were used for further experiments.
| Induction of EndMT, chondrogenic differentiation and osteogenic differentiation
For the EndMT induction, RAOECs were cultured in ECM in the presence of BMP-4 (100 ng/mL), TGF-β2 (100 ng/mL), GNF4837(100 ng/ mL) or NT-3 (100 ng/mL) (R&D Systems) for 2 weeks. For chondro- 
| Cell viability assay
After the induction of EndMT for 48 hours, cell viability was quantified using a Cell Counting Kit-8 (CCK-8, Dojindo, Japan) assay according to the manufacturer's instructions. The number of viable cells in each well was measured at an absorbance wavelength of 450 nm.
| Scratch and transwell migration assays
The migratory ability of ROAECs was measured using the scratch and transwell migration assays after EndMT for 48 hours. For the scratch assay, cells were plated in dishes and a scratch was made in the cell monolayer with a P200 pipette tip. The cells were then incubated under 5% CO 2 at 37°C and photographed for up to 48 hours.
Closure of the scratch area was analysed using Image-Pro Plus 
| Cell staining
ROAECs were grown in osteogenic or chondrogenic medium after EndMT induction. To detect matrix calcification and chondrocyte proteoglycans, Alizarin Red (Sigma-Aldrich) and Alcian Blue (SigmaAldrich) staining were performed on the cultures grown in chondrogenic or osteogenic medium for 14 days. The images were collected from three independent experiments.
| Western blot analysis
RAOECs lysates from the experimental and control groups were collected and prepared for western blot. We incubated primary antibodies (1000-fold) against Tie-1 (Abcam, ab27851), VE-cadherin
(Abacm, ab157107), CD90 (Abacm, ab225), OCN (Abcam, ab13420),
) and GAPDH (ZSGB-Bio, China) overnight at 4°C followed by incubation with an anti-IgG horseradish peroxidase-conjugated secondary antibody (1:4000) for 1 hour. Chemiluminescence was detected using an enhanced chemiluminescence system. GAPDH served as a loading control.
| Statistical analysis
All in vitro data are representative of three independent experiments and each experiment was performed in triplicate. In vivo data represent n = 6 rats/group. SPSS 20.0 (SPSS, Chicago, IL, USA)
was used for statistical analysis and all values are presented as the mean ± SD. The results were compared by one-way ANOVA followed by the least significant difference post hoc test and Student's t test. P < 0.05 was considered statistically significant.
| RE SULTS
| Heterotopic cartilage and bone in HO are induced by EndMT
To examine the pathogenesis of HO, we utilized the rat Achilles ten- 
| NT-3 and TrkC are up-regulated during HO formation
To investigate the expression of NT-3 and TrkC during HO formation, we profiled the mRNA levels of NT-3 and TrkC in the injured Achilles tendons in rats; a normal Achilles tendon served as the control.
Compared with those in the control group, the mRNA levels of NT-3
were increased from 4 through 12 weeks after injury ( Figure 2A ).
NT-3 showed the highest induction at 4 weeks (exceeding 80-fold), and its expression was gradually down-regulated until 12 weeks ( Figure 2A ). Similarly, TrkC mRNA expression was significantly increased more than 70-fold compared with that in the control group at 4 weeks ( Figure 2B ) and a progressive decline in its expression was observed during HO formation ( Figure 2B ).
To visualize the expression of NT-3 and TrkC, we conducted IHC staining of NT-3 and TrkC during HO formation. IHC staining of NT-3
and TrkC was rarely found in the normal Achilles tendon ( Figure 2C 
| Effect of NT-3 on bone formation in HO
Because MSCs are multi-potent, we next investigated the function of NT-3-induced RAOECs on heterotopic bone formation in vitro.
Cells were cultured to induce EndMT for two weeks followed by culture in chondrogenic or osteogenic differentiation medium for another 2 weeks. NT-3, BMP-4 and TGF-β2 markedly enhanced
Alcian Blue and Alizarin Red staining ( Figure 5A ) and significantly 
| Rescue effect of Dorsomorphin on the induction of EndMT and HO formation by NT-3
Dorsomorphin is known to inhibit the EndMT process, Figure 7C, 7) , which was similar with the effect of Dorsomorphin.
To further illustrate the effect of NT-3 on bone formation in HO, both rhNT-3 and GNF5837 treatments were utilized with the injured Achilles tendons using the HO group and saline treatment as controls. In comparison with the HO control group and saline group at 12 weeks by micro-CT scanning, rhNT-3 obviously promoted HO formation whereas GNF5837 showed the opposite effects ( Figure 8A Representative images from one of three experiments are shown (n = 6/group). All data represent the mean ± SD. *P < 0.05, **P < 0.005 and ***P < 0.001 versus the HO control group. ### P < 0.001 versus the rhNT-3 group Neuroendocrine cytokines have been demonstrated to be involved in the maintenance of the skeletal system, as they directly regulate osteoblastic function. 29, 30 In the past, several studies have reported that NT-3, a key molecule for the development and maintenance of the nervous systems 31 acts as a neuroendocrine regulator in the neoangiogenesis of ischemic muscles, remodeling and repair of injured skin as well as wound healing in diabetes mellitus patients. 14, 29, 32 However, detailed reviews that elucidate the role and regulation mechanism of NT-3 in EndMT are still absent. Interestingly, increasing evidence implies the important neuroendocrine role of NT-3 in regulating skeletal system remodeling. 12, 33, 34 Previously, NT-3 treatment was found to accelerate osteogenic differentiation in periodontal ligament cells and cementoblasts. 35 In addition, a previous study demonstrated that a local Although we have observed that endogenous NT-3 and TrkC were notably induced at the sites of HO, unfortunately, the potential sources of endogenous NT-3 in this study remained unknown.
| D ISCUSS I ON
We rarely found the expression of endogenous NT-3 ( Figure 2a) and TrkC (Figure 2e ) in the normal Achilles tendons suggesting that NT-3 may be not produced by the resident cells of normal Achilles tendons. It is reported that, apart from nervous system and skeletal diseases, NT-3 has been regarded as a clinical indicator and can be elevated in various disorders occurred in skin, lung and ovary. NT-3 can be examined from serum either in patients with inflammation or normal people 37 In conclusion, our study is the first step to identify the potential role of NT-3 in EndMT induction and HO formation. We reveal that NT-3 may act as neuroendocrine regulator to promote the pathogenesis of HO formation via modulating EndMT both in vivo and in vitro. Suppression of these NT-3-induced effects by dorsomorphin and GNF5837 can obviously decrease HO formation. In this study, our findings shed new light on the role and action mechanism of NT-3 as a neuroendocrine regulator in the pathogenesis of HO associated with EndMT ( Figure 9 ), which offers potential therapeutic targets for the management of HO.
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